Intellia Therapeutics
Gillian O’Connell is a seasoned Business Analyst with extensive experience in the biotechnology and finance sectors. Currently serving as a Business Analyst II at Intellia Therapeutics, Inc. since October 2018, Gillian has a proven track record in project support, quality assurance testing, and user training. Prior roles include Business Analyst positions at Leerink Partners LLC and Brown Brothers Harriman, where strategic communication between IT and business teams, development of reporting materials, and analysis of business requirements were key responsibilities. Earlier experience includes financial analysis at Raytheon and internships at EMC and MFS Investment Management, contributing to operational efficiency and client integration processes. Gillian holds a Bachelor's degree in Business Administration from Providence College and a Certificate of Business Analysis from Villanova University.
This person is not in any teams
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.